Form 4: Abbott Laboratories Director John G. Stratton Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director John G. Stratton reports acquisition and disposal of Abbott Laboratories common shares and restricted stock units.
Summary
- On April 26, 2024, John G. Stratton, a director of Abbott Laboratories, reported changes in his beneficial ownership of the company's securities.
- Stratton acquired 1,866 common shares without par value.
- He also disposed of 17,398 common shares.
- These transactions involved restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program, payable in common shares upon separation from service, death, or a change in control.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting changes in beneficial ownership, which carries a neutral sentiment.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.
Stakeholder Impact
- Shareholders are informed about the trading activities of a company director, providing insights into insider perspectives on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 04/26/2024 | Date of transaction involving common shares and restricted stock units. |
| 04/30/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.